Support Grows for Bipartisan Bill to Cap Monthly Insulin Costs at $35 Led by Shaheen, Collins, Warnock, Kennedy

Support Grows for Bipartisan Bill to Cap Monthly Insulin Costs at $35 Led by Shaheen, Collins, Warnock, Kennedy
**Eight additional Senators—four from each party—signed on to the Shaheen-led bill to make insulin more affordable for Americans with diabetes**
(Washington, DC) –Bipartisan legislation to make insulin more affordablefor Americans living with diabetesintroduced this weekby U.S. Senator Jeanne Shaheen (D-NH), Susan Collins (R-ME), Reverend Raphael Warnock (D-GA) and John Kennedy (R-LA) is gaining support on and off Capitol Hill.
There is growing momentum behind the proposal on both sides of the aisle. In addition to Shaheen, Collins, Warnock and Kennedy, U.S. Senators Jacky Rosen (D-NV), Tommy Tuberville (R-AL), Angus King (I-ME), Lisa Murkowski (R-AK), Mark Kelly (D-AZ), Chuck Grassley (R-IA), Tammy Baldwin (D-WI) and Katie Britt (R-AL) now cosponsor the legislation.
TheImproving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Actwould cap the cost of insulin at $35 per month for Americans on private and employer insurance and create a pilot program to provide insulin at the same cost to Americans without insurance. Senator Shaheenpublished a videospeaking to the importance of the legislation.
Endorsements of the bipartisanINSULIN Act:
“Breakthrough T1D commends Senators Jeanne Shaheen, Susan Collins, Raphael Warnock, and John Kennedy for introducing this bipartisan bill to lower the cost of insulin for the millions of Americans who rely on it to live,”said Lynn Starr, Breakthrough T1D’s Chief Global Advocacy Officer.“The INSULIN Act builds on the meaningful progress made in recent years to reduce insulin prices and includes several long-standing priorities for which Breakthrough T1D has advocated. We are proud to support this legislation and urge the Senate to move swiftly to advance it.”
“The American Diabetes Association (ADA) has fought to make insulin affordable across the U.S. Unfortunately, insulin remains unaffordable for almost 30 percent of individuals according to an October 2025 national survey by the American Diabetes Association. Too many individuals have to choose between paying for life-saving insulin or paying for other life necessities like rent or food. The American Diabetes Association is proud to endorse the bipartisan INSULIN Act,”said Lisa Murdock, ADA Chief Advocacy Officer.“This legislation takes critical steps to improve access to and limit-out-of-pocket costs for people with private insurance who rely on insulin to live. The ADA strongly urges Congress to act without delay to pass the INSULIN Act.”
“Making insulin more affordable for people living with diabetes is a top priority for the members of the Endocrine Society,”said the Endocrine Society’s Chief Medical Officer Robert W. Lash, M.D.“We applaud the leadership of Senators Shaheen, Collins, Warnock and Kennedy to address this ongoing crisis. For years, our members have been alarmed about the lack of access to affordable insulin. We are pleased to endorse this historic legislation, which will make insulin more affordable for people enrolled in private insurance and people who are uninsured and need access to this lifesaving medication. This legislation will change and save lives. We stand ready to work with you to pass this critically important legislation.”
ClickHEREto view bill text.
INSULIN Actin the news:
###